A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
12/2006
12/20/2006	CN1879629A Estrogen replacement therapy
12/20/2006	CN1879619A Cancer treatment
12/20/2006	CN1879608A Bioadhesive progressive hydration tablets
12/20/2006	CN1879598A Components of Chinese herbal facial mask for beauty treatment and method for preparing same
12/20/2006	CN1290848C Beta-amino tetrahydroimidazo (1,2-a) pyrazines and ahydrotrioazolo (4,3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/20/2006	CN1290846C Pyrazolo[1,5-a]pyridines and medicaments containing thereof
12/20/2006	CN1290842C Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor
12/20/2006	CN1290559C Medicine composition for treating osteoporosis
12/20/2006	CN1290552C Ointment for treating closed fracture
12/20/2006	CN1290551C Combination of Chinese traditional medicine in use for invigorating the kidney and strengthening bone
12/20/2006	CN1290550C Chinese medicine composition for treating rheumatism, rheumatoid, hyperosteogeny and fracture and preparing method thereof
12/20/2006	CN1290548C Traditional Chinese medicine for treating bone fracture and rheumatic diseases
12/20/2006	CN1290542C Chinese medicinal composition for treating ankylosing spondylitis
12/20/2006	CN1290537C Externally applied medicine for treating hyperosteogeny, mammary gland lobule proliferation and mammary fibroma and method for preparing same
12/20/2006	CN1290529C Medicine for treating gout, hyperuricemia and hyperlipemia and preparation method thereof
12/20/2006	CN1290521C Chinese medicine preparation for treating necrosis of femoral head
12/20/2006	CN1290501C Pharmaceutically active isoindoline derivatives
12/19/2006	US7151176 5-[(4-aminopiperidin-1-yl)methyl]-N-[(1R)-1-phenylethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine for example; antiproliferative agents; inhibit tyrosine kinase activity of growth factor receptors such as HER1, HER2 and HER4
12/19/2006	US7151175 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same
12/19/2006	US7151118 N-(6-Methyl-4'-{[3-(4-methylpiperazin-1-yl)propylamino]carbonyl}-1,1'-biphenyl-3-yl)-2-pyrrolidin-1-ylisonicotinamide; enzyme inhibitors for the treatment of certain diseases and conditions; chemical synthesis
12/19/2006	US7151109 Psychological disorders; anxiolytic agents; antidepressants
12/19/2006	US7151101 For prevention/treatment of cancer, inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, viral diseases and neurodegenerative diseases
12/19/2006	US7150983 Modified proteolytic enzyme for treatment of osteoarthritis
12/14/2006	WO2006132583A1 Method and means for preventing and inhibiting respiratory disease, atherosclerosis and osteoporosis caused by chlamydia pneumoniae infection
12/14/2006	WO2006132442A1 Vitamin d-like compound
12/14/2006	WO2006132438A1 1,3-benzothiazinone derivative and use thereof
12/14/2006	WO2006132388A1 Bone marrow-directing drug delivery materials and their applications
12/14/2006	WO2006132205A1 Radical scavenger and active oxygen eliminating agent
12/14/2006	WO2006132204A1 Transcription factor decoy
12/14/2006	WO2006131186A1 Oxindoles as kinase inhibitors
12/14/2006	WO2006111776A3 Pharmaceutical composition comprising serum obtained from a naive mammal
12/14/2006	WO2006108424A3 Beta-2 adrenoceptor agonists for treating connective tissue diseases of the skin
12/14/2006	WO2006101977A3 Pyrimidine compounds and methods of use
12/14/2006	WO2006031376A3 Use of antioxidants for treating degenerative disc disease
12/14/2006	WO2001022972A9 Immunostimulatory nucleic acids
12/14/2006	US20060281887 (Meth)acrylate copolymer for use as medical carrier
12/14/2006	US20060281761 Osteoporosis; oral diseases; bone disorders; atherosclerosis; antiarthritic agents; autoimmune disease; cachexia
12/14/2006	US20060281742 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
12/14/2006	US20060281734 3-[5-(3-acetamidobenzamido)-2-methylphenyl]-6-(4-methylpiperazin-1-yl)-3,4-dihydroquinazolin-4-one for example; treating rheumatoid arthritis, osteoarthritis, psoriasis, chronic obstructive pulmonary disease; inhibitor of cytokine-mediated disease
12/14/2006	US20060281726 Piperidine derivatives for the treatment of chemokine or h1 mediated disease state
12/14/2006	US20060281719 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase
12/14/2006	US20060281714 Combinations of a cathepsin k inhibitor and a bisphosphonate in the treatment of bone metastasis, tumor growth and tumor-induced bone loss
12/14/2006	US20060281706 New phosphonate ester derivatives of drugs such as antivirals cidofovir, adefovir, tenofovir, azidothymidine (AZT), or bisphosphonates such as alendronate, or anticancers such as cytosine arabinoside; side effect reduction, less toxic; antiviral
12/14/2006	US20060281704 Regulation of endogenous gene expression in cells using zinc finger proteins
12/14/2006	US20060280820 Use of an extract of Aloysia/Verbena/Lippia triphylla/citriodora for the treatment of chronic and/or inflammatory diseases
12/14/2006	US20060280749 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor
12/14/2006	US20060280741 Administering the antibody concurrently with an antagonist of IL-1 alpha to treat psoriatic arthritis; arthritis nodosa; seronegative spondylarthropathy, and ulcerative colitis
12/14/2006	US20060280719 An addition polymer from an unsaturated monomer containing a phosphonate group and a phosphinate group separated from eachother by an optionally fluorinated methylene group; treatment of hyperphosphotemia, chronic renal failure, hyperparathyroidism, uremic bone disease, or osteoporosis
12/14/2006	CA2614295A1 Transcription factor decoy
12/14/2006	CA2611401A1 Oxindoles as kinase inhibitors
12/13/2006	EP1731608A1 Marker gene for arthrorheumatism test
12/13/2006	EP1731193A1 Electro-medical device for use with biologics
12/13/2006	EP1731168A1 Antibody drug
12/13/2006	EP1731157A2 Pharmaceutical compositions and uses for androst-5-ene-3 beta,17 beta-diol
12/13/2006	EP1731131A1 Hgf production accelerator containing heparin-like oligosaccharide
12/13/2006	EP1729831A1 Preparation of a nucleated cell and/or platelet concentrate from a physiological solution
12/13/2006	EP1501523A4 Carbon monoxide as a biomarker and therapeutic agent
12/13/2006	EP1436877B1 An intelligent serial battery charger and charging block
12/13/2006	EP1425014B1 Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as ppar activators
12/13/2006	EP1383765B1 Carboline derivatives as inhibitors of phosphodiesterase 5 (PDE5) for the treatment of cardiovascular diseases and erectile dysfunction
12/13/2006	EP1261712B1 Proteins named fctrx and nucleic acids encoding same
12/13/2006	EP1123392B1 Prv-1 gene and the use thereof
12/13/2006	EP1117795B1 Tgf-beta superfamily mutant members, including morphogenic proteins
12/13/2006	CN1876683A Human antibodies that bind human TNFalpha
12/13/2006	CN1876642A Cnidium fruit essence crystal and preparation method and uses
12/13/2006	CN1876634A Sinomenine structure-modified compound and its preparation method
12/13/2006	CN1876162A Plaster for treating orthopaedic diseases and its preparation process
12/13/2006	CN1876156A Chinese medicinal ointment for treating bones and tendons injury pain
12/13/2006	CN1876154A Pain-relieving plaster and preparation method thereof
12/13/2006	CN1876148A A Chinese medicinal composition for replenishing kidney and strengthening bone and preparation method thereof
12/13/2006	CN1876140A Waist- and bone-strengthening liquid
12/13/2006	CN1876136A A Chinese medicinal composition for treating lumbar intervertebral protrusion
12/13/2006	CN1876130A A medicinal plaster and method for making same
12/13/2006	CN1876124A Wind-expelling pain-stopping capsule
12/13/2006	CN1876122A Medicinal ointment for treating hyperosteogeny, wind-cold-damp Bi, strain and sprain and preparation method thereof
12/13/2006	CN1876121A A medicinal wine capable of treating multiple diseases
12/13/2006	CN1876120A A medicine for treating rheumatoid arthritis and hyperosteogeny and preparation method thereof
12/13/2006	CN1876115A An externally applied Chinese herbal composition for treating scapulohumeral periarthritis
12/13/2006	CN1876114A A medicine for treating hyperosteogeny and preparation method thereof
12/13/2006	CN1876084A Ointment for orthopedics
12/13/2006	CN1876082A A Chinese medicine for treating femoral head necrosis and preparation method thereof
12/13/2006	CN1876081A A medicinal tincture and method for preparing same
12/13/2006	CN1876080A Bolus for treating collateral and gynecological disease
12/13/2006	CN1876076A Chinese medicinal composition for treating periarthritis humeroscapularis and method for preparing its preparation
12/13/2006	CN1876058A A medicine for treating ankylosing spondylitis and preparation method thereof
12/13/2006	CN1876043A Chinese herbal foot-bathing agent with tendon-relaxing fatigue-relieving functions
12/13/2006	CN1876041A A compound Chinese medicine for treating bone fracture quickly
12/13/2006	CN1876036A A Chinese medicine for treating hyperosteogeny and preparation method thereof
12/13/2006	CN1876035A Pain-relieving tincture
12/13/2006	CN1876019A An injection containing phenylpropanolid glycosides, its preparation method and use
12/13/2006	CN1876018A A herbal extract, its preparation method and use
12/13/2006	CN1876015A A medicament for treating rheumatism
12/13/2006	CN1876010A Preparation method of estrogen activity-possessed red clover extractive and extractive thereof
12/13/2006	CN1875997A Application of sundew in pharmaceutical preparation
12/13/2006	CN1875988A Method for preparing low molecular weighted glucidamin collagen composition, its product and use
12/13/2006	CN1289671C Antibody molecules having specificity for human tumor necrosis factory alpha, and use thereof
12/13/2006	CN1289490C Oxa-and thiazole derivatives useful as antidiabetic and antibesity agents
12/13/2006	CN1289483C Heterocyclic derivatives of glycinamide and its pharmaceutical uses
12/13/2006	CN1289472C Hydroxamic acid derivatives and medicinal utilization thereof
12/13/2006	CN1289471C 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

1 ... 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 ... 820